# Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis

> **NCT00470171** · PHASE2 · COMPLETED · sponsor: **Axcan Pharma** · enrollment: 98 (estimated)

## Conditions studied

- Serum Levels of ALAT Transaminases
- Serum Markers for Fibrosis and Hepatic Inflammation

## Interventions

- **DRUG:** Ursodesoxycholic acid

## Key facts

- **NCT ID:** NCT00470171
- **Lead sponsor:** Axcan Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2009-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00470171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00470171, "Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00470171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*